| Subject | Date | ||||||
|---|---|---|---|---|---|---|---|
| Fabrazyme Stakeholders Working Group Guidance | 02/29/2012 | ||||||
| Fabrazyme Supply Update 1-26-12 | 02/29/2012 | ||||||
| FDA Approvals Framingham Manufacturing Plant | 02/29/2012 | ||||||
| MRI Research Study at MGH | 02/29/2012 | ||||||
| Pharmacological Treatment Option | 02/29/2012 | ||||||
| Dr. Paul M. Fernhoff endowment and Hospice room in honor | 02/29/2012 | ||||||
| Rare Disease Day | 02/29/2012 | ||||||
| Wednesday's Quote | 02/01/2012 | ||||||
| Amicus Positive Preliminary Co-Administration Results | 01/31/2012 | ||||||
| Children | 01/31/2012 | ||||||
| CALLING ALL GEEKS!!! | 01/31/2012 | ||||||
| |||||||
| Emory Meet YOUR LSDC Team of Doctors | 01/29/2012 | ||||||
| Family Assistance Program | 01/27/2012 | ||||||
| |||||||
| |||||||
| Wednesday's Quote | 01/25/2012 | ||||||
| Beginning in March, all U.S. patients currently on therapy will return to full dosing, according to Sanofi. | 01/24/2012 | ||||||
| |||||||
| |||||||
| |||||||
| Exacerbation | 01/24/2012 | ||||||
| |||||||
| Fabrazyme Update. | 01/24/2012 | ||||||
| |||||||
| |||||||
| Heart thickness increasing? | 01/23/2012 | ||||||
| |||||||
| |||||||
| |||||||